undamentalytics Newsletter
Sign in

Equifax (EFX) stock

Add to watchlist

Add holding +

NYSE: EFX NYSE Research & Consulting Services Next results ~February 3, 2027

B Fundamentals grade

Equifax is a global data, analytics and technology company providing information solutions to businesses, governments and consumers, alongside human resources process automation and outsourcing services for employers. Its databases draw on credit, financial, employment, income, education, criminal justice, healthcare licensure and marketing data, processed using statistical modelling, artificial intelligence and proprietary software to create decision-making tools and risk assessments.

Clients span financial institutions, mortgage lenders, employers, government agencies, insurers and retailers, with fees typically charged per transaction or through data licensing; consumers also pay directly for credit monitoring and identity-protection products. Key offerings include The Work Number, an employment and income verification platform holding around 209 million active records, alongside credit reporting, fraud detection, identity verification, marketing analytics and debt-collection support services.

The company is organised into three segments: Workforce Solutions, U.S. Information Solutions, and International, the latter covering Latin America, Europe, Asia Pacific and Canada, plus joint ventures in Brazil, Cambodia, Malaysia and Singapore. International clients accounted for 23% of total revenue in 2025. Equifax traces its origins to 1899, with the present corporation incorporated in Georgia in 1913, and is headquartered in Atlanta.

Based on Equifax's 10-K filed February 19, 2026.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$200

Cash-flow model

Base case. Range ~$140–$280 across our lower- and higher-growth cases (4.8%–14.8% a year).

Price vs value

Modestly undervalued

The price is inside our value range, 3% below our base value.

Price used: $192.51, November 2, 2026

Equifax valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

Value diary

Our note on each quarter Equifax files

10-Q filed October 20: Equifax

Model value −2.3%

Revenue for the twelve months to September 2026 was $6.59bn, up 10.9% on a year earlier, faster than the 10.3% growth a quarter earlier. Free-cash-flow margin held at 16.7%. The diluted share count is down 3.7% on a year earlier, which lifts each remaining share. Its fundamentals grade moves from C+ to B. Our model value falls from $201 to $197 a share, against a share price of $184. The rating stays Hold. At that price, our model says the market is pricing in about 7.5% a year of cash-flow growth for five years, close to the 6.0% a year revenue growth it has delivered.

Source: 10-Q filed October 20, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (2)

10-Q filed July 21: Equifax

Trailing twelve-month revenue reached $6.59bn to June 2026, up 10.9% on a year earlier. That marks an acceleration from the 10.3% pace recorded a quarter before. Free-cash-flow margin held steady at 16.7%. The diluted share count has fallen 3.7% over the year, so each remaining share claims more of the business. We lift our model value from $156 to $169 a share, though the stock trades at $177. The rating stays Hold. At today's price, our model implies the market expects cash flow to compound at roughly 10.4% a year for five years. That runs well ahead of the 6.0% annual revenue growth the company has actually delivered.

10-Q on SEC EDGAR

Where Equifax stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $6.44bn, up 10.3% on a year earlier, faster than 9.6% a quarter earlier. Free-cash-flow margin rose to 17.1% from 15.7% a year earlier. The diluted share count is down 2.8% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades C+. It passes 3 of our 7 financial-health checks. Our cash-flow model value is $156 a share, against a share price of $175. At that price, our model says the market is pricing in about 11.2% a year of cash-flow growth for five years, faster than the 5.5% a year revenue growth it has delivered.

10-Q on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 3, 2027 (estimated)

Equifax's trailing-twelve-month revenue grew 10.9% year on year, with a free-cash-flow margin of 16.7%. Where it stands out: free-cash-flow margin of 16.7% ranks 4 of 33 research & consulting services companies we cover. Where it lags: long-term debt as % of assets of 42.3% ranks 17 of 21 research & consulting services companies we cover.

Our discounted-cash-flow model values the business at ~$200 per share in the base case (~$140–$280 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Revenue growth accelerating: TTM revenue growth rose to 10.9% (+0.6pp vs the prior quarter).

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Shrinking share count. Diluted shares fell 3.7% in a year, so each share owns more of the business.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Below peers: long-term debt as % of assets. Long-term debt as % of assets of 42.3% ranks 17 of 21 research & consulting services companies we cover (median 22.7%).
  • Estimates being cut. Analysts' consensus for next year's earnings per share has fallen 5.5% over 90 days.

Latest results: FY2026 Q3

Filed October 20, 2026
Earnings per share
$2.26 against an average estimate of $2.20: beat by 2.8%
Revenue
$1.69bn, up 9.6% on a year earlier
Share reaction
+10.7% in the first session after the results on October 20, 2026, against +0.9% for the S&P 500
Guidance given
reported Revenue $1.61bn to $1.64bn (Q4 2026); reported Revenue $6.65bn to $6.68bn (FY 2026)
Next report
October 20, 2026; average EPS estimate $2.13

Equifax's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+4.3%
  • 1 week+7.8%
  • 1 month+37.5%
  • This year-10.5%
  • 1 year-7.8%
  • 5 years-27.9%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$6.6B
Operating margin
18.8%
Net margin
11.3%
EPS (TTM, diluted)
$6.19

Growth

Revenue growth
+10.9%
Change in growth rate
+0.6 pts
Share count change
−3.7%

Cash

Free cash flow (TTM)
$1.1B
FCF margin
16.7%
Stock pay % of revenue
1.4%

Earnings

Last results
October 20, 2026
Next results (est.)
February 3, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Insider trade
  2. Announcement
  3. Results
  4. Guidance
  5. Product
  6. Announcement
  7. Announcement
  8. Announcement
  9. Announcement
  10. Product
  11. Announcement
  12. Dividend
  13. Announcement
  14. Insider trade
  15. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Equifax valuation models and calculator

What the price is pricing in

The share price implies about 7.9% a year of cash-flow growth for five years.That is close to the 6.0% a year revenue growth Equifax has delivered.

  • Priced in7.9%
  • Last 12 months10.9%
  • 3 years a year8.7%
  • 5 years a year6.0%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($185.12, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Hold12-month view
12-month price target
~$200
Price used
$185.12close November 3, 2026
Implied change
▲ +7%
Uncertainty
Medium

How we got here: a discounted-cash-flow model of Equifax's free cash flow after stock-based pay with after-tax interest added back ($1.2B, FY2026 Q3 TTM), growing 7% and 8.5% in the next two years (forecasts, guidance and its record), then back to 9.8% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$140–~$280 ; that spread sets a 25% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Equifax's free cash flow after stock-based pay ( $1.2B, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Equifax as an operating company, with every model that fits that kind of business. Cost of equity 9.1%: the 10-year Treasury yield (4.9%) plus a beta of 0.91 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$200 ~$140–$280 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$110 ~$130–$190 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$69 ~$50–$97 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$74 ~$64–$89 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$130 ~$69–$200 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Equifax with Research & Consulting Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −29%
  • Revenue growth 5 points higher ▲ +37%
  • Free-cash-flow margin 1 point lower ▼ −6%
  • Last year's free-cash-flow margin change, if it persists ▼ −0%
  • Discount rate 1 point higher ▼ −18%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $98$149$216$305$421$571
8.5% $64$101$150$213$296$403
10% $44$73$110$159$222$302

Valuation multiples over time Market data may be delayed

At fiscal year end 2016201720182019202020212022202320242025Now
Share price$107.79$108.81$87.10$132.66$184.39$281.82$188.56$241.70$250.58$215.03$192.51
Market value$13.1bn$13.2bn$10.6bn$16.2bn$22.6bn$34.8bn$23.2bn$29.9bn$31.3bn$26.7bn$23.1bn
+ Net debt (− = net cash)$2.6bn$2.4bn$2.4bn$3.0bn$2.7bn$5.1bn$5.5bn$5.5bn$4.9bn$4.9bn$5.0bn
Enterprise value$15.6bn$15.6bn$13.0bn$19.2bn$25.4bn$39.9bn$28.8bn$35.5bn$36.2bn$31.6bn$28.2bn
Multiples
Price / sales 4.2x3.9x3.1x4.6x5.5x7.1x4.5x5.7x5.5x4.4x3.5x
Price / earnings 26.7x22.5x34.1x—43.5x46.8x33.4x54.9x51.8x40.4x31.1x
Price / free cash flow 20.1x22.1x30.2x—43.1x40.2x175.3x58.1x38.5x23.5x20.9x
EV / EBITDA 14.3x13.9x17.0xn/m23.6x24.5x17.7x22.8x21.0x17.4x14.1x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

42 /100

Weak moat

How hard Equifax's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 8 / 20

    Net income has been a median 5.9% of total assets over 10 years.

  • Durability 5 / 20

    Operating margin has been a median 17.9%; its worst year was -9.8%.

  • Cash conversion 15 / 20

    Free cash flow was positive in 8 of 9 years, at a median 13.1% of revenue.

  • Discipline 18 / 20

    The diluted share count fell 2.6% over five years; stock-based pay has been a median 1.4% of revenue.

AI disruption exposure: High. In this industry, the core product is information work that AI systems increasingly perform. The score above includes a 15-point deduction for that exposure (57 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $8.51 +11% $6.7bn +10%
Next $9.55 +12% $7.1bn +6%

Next year's EPS estimate has moved −5.5% in 90 days, across 20 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −0.6% on 90 days ago. In the last 30 days, 0 analysts raised Equifax's forecast and 8 cut it.

Consensus EPS forecast Equifax, last 90 days
$8.00 $8.50 $9.00 $9.50 $10.00 $10.50 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $8.56 Current fiscal year, 60 days ago: $8.55 Current fiscal year, 30 days ago: $8.55 Current fiscal year, 7 days ago: $8.48 Current fiscal year, Now: $8.51 $8.51 Next fiscal year, 90 days ago: $10.11 Next fiscal year, 60 days ago: $10.10 Next fiscal year, 30 days ago: $10.08 Next fiscal year, 7 days ago: $9.69 Next fiscal year, Now: $9.55 $9.55

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $8.56$10.11
60 days ago $8.55$10.10
30 days ago $8.55$10.08
7 days ago $8.48$9.69
Now $8.51$9.55

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $2.20 $2.26 +2.8%
Jun 2026 $2.20 $2.25 +2.3%
Mar 2026 $1.70 $1.86 +9.7%
Dec 2025 $2.05 $2.09 +1.8%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 20, 2026
  • Reported Revenue FY 2026 $6.646bn to $6.676bn Lowered
    “Reported Revenue $1.605 billion $1.635 billion $6.646 billion $6.676 billion” source
  • Reported Revenue Growth FY 2026 9.4% growth to 9.9% growth
    “Reported Revenue Growth 3.5% 5.4% 9.4% 9.9%” source
  • Local Currency Growth FY 2026 8.5% growth to 9% growth
    “Local Currency Growth (1) 3.1% 5.0% 8.5% 9.0%” source
  • Organic Local Currency Growth FY 2026 8.4% growth to 8.9% growth
    “Organic Local Currency Growth (1) 3.0% 4.9% 8.4% 8.9%” source
  • full year 2026 revenue guidance full year 2026 about $6.661bn Lowered
    “As a result, we are reducing our full year 2026 revenue guidance at the midpoint to $6.661 billion, reflecting this reduction in our U.S. Mortgage related revenue.” source
  • Reported Revenue Q4 2026 $1.605bn to $1.635bn
    “Reported Revenue $1.605 billion $1.635 billion $6.646 billion $6.676 billion” source
Show 6 more items
  • Reported Revenue Growth Q4 2026 3.5% growth to 5.4% growth
    “Reported Revenue Growth 3.5% 5.4% 9.4% 9.9%” source
  • Local Currency Growth Q4 2026 3.1% growth to 5% growth
    “Local Currency Growth (1) 3.1% 5.0% 8.5% 9.0%” source
  • Organic Local Currency Growth Q4 2026 3% growth to 4.9% growth
    “Organic Local Currency Growth (1) 3.0% 4.9% 8.4% 8.9%” source
  • Adjusted Earnings Per Share FY 2026 $8.45 to $8.55 Non-GAAP Lowered
    “Adjusted Earnings Per Share $2.07 per share $2.17 per share $8.45 per share $8.55 per share” source
  • 2026 Adjusted EPS Guidance 2026 about $8.50 Non-GAAP Lowered
    “Despite the impact of the significantly weakened U.S. mortgage market on the second half of 2026 revenue, we expect to deliver 2026 Adjusted EPS Guidance of $8.50 per share, a reduction of only $0.04 per share at the midpoint and well within our previous Guidance range.” source
  • Adjusted Earnings Per Share Q4 2026 $2.07 to $2.17 Non-GAAP
    “Adjusted Earnings Per Share $2.07 per share $2.17 per share $8.45 per share $8.55 per share” source

How earlier guidance turned out

  • Reported Revenue, Q3 2026 guided $1.68bn to $1.71bn Within range: $1.6925bn

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows Equifax's revenue by +7.0% next year and +8.5% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+6.1%, weight 57%) , management guidance (+6.0%, weight 19%) and the company's own record (+9.8%, weight 25%) . How the weights are set.

Analyst recommendations

24 analysts, Oct 2026
Buy1771%
Hold729%
Sell00%

Monthly trend

  1. Oct 2026413724
  2. Sep 2026613524
  3. Aug 2026413724
  4. Jul 2026412824

Counts of recommendations published by analysts covering Equifax, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
5.5%
of tradable shares
Days to cover
2.86
at average volume
Short interest, 1 month
−27%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
0.6%
of shares
Employees
15,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −7.8%

$208.71 on October 31, 2025 to $192.51

ThenNowEffect
Revenue (last 12 months) $5.8bn $6.4bn +10.3%
Net margin 11.0% 10.7% −2.1%
P/E multiple 40.8x 33.9x −17.0%
Share count 125m 122m +2.8%

Biggest factor: p/e multiple.

Last 3 years +8.5%

$177.38 on November 3, 2023 to $192.51

ThenNowEffect
Revenue (last 12 months) $5.1bn $6.4bn +27.3%
Net margin 10.4% 10.7% +3.5%
P/E multiple 41.7x 33.9x −18.9%
Share count 123m 122m +1.5%

Biggest factor: revenue.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
EFX+53%−33%+28%+4%−14%−11%
Industry peers (median)+34%−15%+10%−4%−15%−0%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
EFX75%25%67%42%58%46%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
EFX−16%−48%−32%−21%−27%−39%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 54% from September 13, 2024 to September 30, 2026. Getting back needed a 119% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$137.24 – $224.92
From 52-week high
−14.4%
vs 50-day average
+15.8%
vs 200-day average
+9.4%
Volatility (1 year)
41%
Beta vs S&P 500
0.46

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
4 up, 8 down
typical move ±6.7%
After a week
5 up, 7 down
typical move ±7.7%
After a month
6 up, 5 down
typical move ±11.0%
Results releasedNext dayS&P 500 next day5 days21 days
October 20, 2026 +10.7% +0.9% +10.8% —
July 21, 2026 −5.3% +0.7% +3.9% +6.7%
April 21, 2026 −10.0% +0.4% −13.5% −16.9%
February 4, 2026 +9.1% −1.7% +12.9% +18.7%
October 21, 2025 −0.2% −0.5% −3.0% −10.8%
July 22, 2025 −5.3% +0.9% −4.8% −4.3%
April 22, 2025 +15.8% +4.2% +20.1% +20.1%
February 6, 2025 −8.1% −0.6% −7.2% −7.4%
October 16, 2024 −3.4% +0.4% −6.3% −9.6%
July 17, 2024 −0.2% −2.2% −1.4% +10.9%
April 17, 2024 −8.8% −0.8% −5.4% +4.8%
February 7, 2024 +3.6% +0.9% +2.9% +11.2%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Equifax’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Implied vs realised volatility

Options look cheap

Option prices imply less movement than the shares have recently shown. Selling options pays little for the risk taken.

  • Implied is 0.99× the last 60 days’ realised volatility , richer than 18% of the 229 stocks we screen today.
  • Puts are priced 2 points richer than calls (25-delta): the market is paying up for downside protection, which favours selling puts over calls.
  • Why: implied is below 60-day realised: selling options pays little for the risk taken.

Our rule for “rich”: implied at least 1.2× 60-day realised (beyond measurement noise), above 1-year realised (not just a calm spell), and in the top 20% of our coverage that day. Never with results inside the option’s life. These are our conventions, built on research showing option prices usually imply more movement than follows, most when the gap is wide. How we judge this.

Cash-secured put

Not offered: fundamentals grade B (needs B+ or better).

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

EFX Equifax Grade B $192.13

Own 100 shares, sell the $210 call expiring December 18, 2026 (46 days) for $4.00 a share — $400 per contract.

Previous session · Bid $4.00, ask $5.40, quoted Mon 2 Nov, 17:22 New York time with EFX at $192.13. Option prices move with the shares: check the live chain at your broker before trading.

  • If EFX ends below $210: you keep your shares and the $400 — 2.1% extra on the position, 16.5% a year at that pace.
  • If it ends above $210: your shares are sold at $210, a total return of 11.4% including the premium — at or above our value of ~$200.
$2.2k $0 −$3.8k Break-even $188.13 Price $192.13 Our value $200
Profit or loss per contract at expiry, by share price (including the shares bought at today's price).
Premium
$400
Annualised
16.5%
Break-even
$188.13
Max gain
$2,187.25
Chance of selling
~31%

Collar

Not offered: the shares trade below our fair value: a collar caps upside the model expects.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Equifax in five measures

Fundamentals grade B
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Equifax
$5B $5.5B $6B $6.5B $7B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $5.3B Revenue (TTM), FY24 Q1: $5.4B Revenue (TTM), FY24 Q2: $5.5B Revenue (TTM), FY24 Q3: $5.6B Revenue (TTM), FY24 Q4: $5.7B Revenue (TTM), FY25 Q1: $5.7B Revenue (TTM), FY25 Q2: $5.8B Revenue (TTM), FY25 Q3: $5.9B Revenue (TTM), FY25 Q4: $6.1B Revenue (TTM), FY26 Q1: $6.3B Revenue (TTM), FY26 Q2: $6.4B Revenue (TTM), FY26 Q3: $6.6B $6.6B

Source: SEC EDGAR filings. Retrieved October 21, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $5.3B
FY24 Q1 $5.4B
FY24 Q2 $5.5B
FY24 Q3 $5.6B
FY24 Q4 $5.7B
FY25 Q1 $5.7B
FY25 Q2 $5.8B
FY25 Q3 $5.9B
FY25 Q4 $6.1B
FY26 Q1 $6.3B
FY26 Q2 $6.4B
FY26 Q3 $6.6B
Revenue growth, TTM YoY Equifax
0% 5% 10% 15% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: 2.8% Revenue growth, TTM YoY, FY24 Q1: 5.8% Revenue growth, TTM YoY, FY24 Q2: 8.0% Revenue growth, TTM YoY, FY24 Q3: 8.8% Revenue growth, TTM YoY, FY24 Q4: 7.9% Revenue growth, TTM YoY, FY25 Q1: 7.1% Revenue growth, TTM YoY, FY25 Q2: 6.9% Revenue growth, TTM YoY, FY25 Q3: 6.4% Revenue growth, TTM YoY, FY25 Q4: 6.9% Revenue growth, TTM YoY, FY26 Q1: 9.6% Revenue growth, TTM YoY, FY26 Q2: 10.3% Revenue growth, TTM YoY, FY26 Q3: 10.9% 10.9%

Source: SEC EDGAR filings. Retrieved October 21, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 2.8%
FY24 Q1 5.8%
FY24 Q2 8.0%
FY24 Q3 8.8%
FY24 Q4 7.9%
FY25 Q1 7.1%
FY25 Q2 6.9%
FY25 Q3 6.4%
FY25 Q4 6.9%
FY26 Q1 9.6%
FY26 Q2 10.3%
FY26 Q3 10.9%
Operating margin (TTM) Equifax
17.5% 18% 18.5% 19% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: 17.7% Operating margin (TTM), FY24 Q1: 17.8% Operating margin (TTM), FY24 Q2: 18.3% Operating margin (TTM), FY24 Q3: 17.9% Operating margin (TTM), FY24 Q4: 18.3% Operating margin (TTM), FY25 Q1: 18.4% Operating margin (TTM), FY25 Q2: 18.5% Operating margin (TTM), FY25 Q3: 18.5% Operating margin (TTM), FY25 Q4: 18.0% Operating margin (TTM), FY26 Q1: 18.3% Operating margin (TTM), FY26 Q2: 17.9% Operating margin (TTM), FY26 Q3: 18.8% 18.8%

Source: SEC EDGAR filings. Retrieved October 21, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 17.7%
FY24 Q1 17.8%
FY24 Q2 18.3%
FY24 Q3 17.9%
FY24 Q4 18.3%
FY25 Q1 18.4%
FY25 Q2 18.5%
FY25 Q3 18.5%
FY25 Q4 18.0%
FY26 Q1 18.3%
FY26 Q2 17.9%
FY26 Q3 18.8%
FCF margin (TTM) Equifax
5% 10% 15% 20% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 9.8% FCF margin (TTM), FY24 Q1: 12.0% FCF margin (TTM), FY24 Q2: 12.4% FCF margin (TTM), FY24 Q3: 14.0% FCF margin (TTM), FY24 Q4: 14.3% FCF margin (TTM), FY25 Q1: 14.1% FCF margin (TTM), FY25 Q2: 15.7% FCF margin (TTM), FY25 Q3: 16.8% FCF margin (TTM), FY25 Q4: 18.7% FCF margin (TTM), FY26 Q1: 18.1% FCF margin (TTM), FY26 Q2: 17.1% FCF margin (TTM), FY26 Q3: 16.7% 16.7%

Source: SEC EDGAR filings. Retrieved October 21, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 9.8%
FY24 Q1 12.0%
FY24 Q2 12.4%
FY24 Q3 14.0%
FY24 Q4 14.3%
FY25 Q1 14.1%
FY25 Q2 15.7%
FY25 Q3 16.8%
FY25 Q4 18.7%
FY26 Q1 18.1%
FY26 Q2 17.1%
FY26 Q3 16.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Equifax took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $6.1B
  2. Selling, general and admin $1.6B · 26.6%
  3. Other operating costs $3.4B · 55.4%
  4. Operating income $1.1B · 18.0%
  5. Income tax $231M · 3.8%
  6. Interest and other $204M · 3.4%
  7. Net income $660M · 10.9%

Shares of revenue. Source: Equifax's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 3,145 3,362 3,412 3,508 4,128 4,924 5,122 5,265 5,681 6,075 6,592
EBITDA 1,094 1,123 764 2 1,076 1,628 1,625 1,553 1,723 1,822 1,996
Operating income 825 832 448 −335 677 1,138 1,056 934 1,042 1,095 1,241
Net income 489 587 311 −384 520 744 696 545 604 660 743
Diluted EPS $4.04 $4.83 $2.56 −$3.15 $4.24 $6.02 $5.65 $4.40 $4.84 $5.32 $6.19
Growth (year on year)
Revenue — +6.9% +1.5% +2.8% +17.7% +19.3% +4.0% +2.8% +7.9% +6.9% +10.9%
EBITDA — +2.6% −32.0% −99.8% — +51.3% −0.2% −4.4% +10.9% +5.8% +10.3%
Operating income — +0.8% −46.1% −174.9% — +68.2% −7.2% −11.6% +11.6% +5.1% +13.0%
Net income — +20.2% −47.1% −223.7% — +43.1% −6.4% −21.7% +10.8% +9.3% +12.8%
Diluted EPS — +19.6% −47.0% −223.0% — +42.0% −6.1% −22.1% +10.0% +9.9% +17.2%
Margins
EBITDA margin 34.8% 33.4% 22.4% 0.1% 26.1% 33.1% 31.7% 29.5% 30.3% 30.0% 30.3%
Operating margin 26.2% 24.7% 13.1% −9.6% 16.4% 23.1% 20.6% 17.7% 18.3% 18.0% 18.8%
Net margin 15.5% 17.5% 9.1% −11.0% 12.6% 15.1% 13.6% 10.4% 10.6% 10.9% 11.3%
Free-cash-flow margin 20.7% 17.8% 10.3% −2.4% 12.7% 17.6% 2.6% 9.8% 14.3% 18.7% 16.7%
Cash flow
Cash from operations 823 816 672 314 946 1,335 757 1,117 1,325 1,616 1,613
Capital spending 174 218 322 400 421 469 625 601 512 481 509
Free cash flow 650 598 350 −86 525 866 133 516 813 1,134 1,104
Stock-based pay 37 38 43 50 55 55 63 72 82 78 89
Free cash flow after stock pay 612 560 308 −136 470 811 70 444 731 1,056 1,015
Balance sheet
Cash 129 336 224 401 1,685 225 285 217 170 181 193
Total debt 2,685 2,715 2,655 3,403 4,402 5,325 5,817 5,742 5,038 5,114 5,233
Net debt (negative = net cash) 2,556 2,379 2,431 3,002 2,718 5,100 5,532 5,525 4,868 4,933 5,040
Diluted shares 121m 122m 121m 122m 123m 124m 123m 124m 125m 124m 120m
Returned to shareholders
Dividends 158 187 188 189 190 190 191 192 193 233 260
Buybacks 0 77 0 0 0 70 0 0 0 928 1,152
Total returned 158 265 188 189 190 260 191 192 193 1,160 1,412

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

4 of 7 checks passed · September 30, 2026
What it owns · $11.9bn
Short-term assets $1.6bnLonger-term assets $10.4bn
What it owes, and who funded it · $11.8bn
Short-term liabilities $1.5bnLonger-term liabilities $5.9bnShareholders' equity $4.5bn
  • Short-term assets cover short-term liabilities $1.6bn of assets due within a year against $1.5bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.6bn short-term assets against $5.9bn of longer-dated liabilities.
  • More cash than debt $193m of cash against $5.2bn of debt.
  • Debt below 40% of shareholders' equity Debt is 116% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 117% to 116% over five years.
  • A year's operating cash flow covers at least 20% of debt $1.6bn of operating cash flow against $5.2bn of debt.
  • Operating profit covers interest at least five times over Operating income of $1.2bn against $232m of interest.

From Equifax's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q3 TTM
Buybacks (TTM)
$1.2B
Dividends (TTM)
$260M
Returned to shareholders
128%
of free cash flow
Buybacks, last 3 fiscal years
$928M
Diluted share count
−3.7%
year over year
Total shareholder yield
6.3%
dividends 1.1% + buybacks 5.1% of market value
Dividend payout ratio
35%
of net income paid out
Sales & admin spending
25.0%
of revenue
Days sales outstanding
61 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in research & consulting services
Last 12 months unless stated EFX PSN TTEK TRU NIQ FCN Median
Revenue, last 12 months $6.6bn $6.3bn $5.1bn $5.0bn $4.4bn $4.0bn $632m
Revenue growth, last 12 months 10.9% −2.7% −7.6% 13.4% 8.9% 7.8% 4.8%
Revenue growth, 3-year average 8.7% 7.8% 6.8% 10.1% — 6.0% 6.8%
Revenue growth, latest quarter 9.6% 1.8% −4.5% 12.2% 8.0% 5.9% 4.4%
Gross margin — 22.2% 18.8% — — 32.2% 43.9%
Operating margin 18.8% 4.8% 12.1% 19.3% 1.9% 8.8% 6.1%
Operating margin, 3-year average 18.4% 5.8% 9.3% 17.2% — 9.8% 6.0%
Net margin 11.3% 2.3% 8.6% 15.8% −8.0% 5.9% 3.1%
Cash from operations / revenue 24.5% 7.8% 11.2% 24.0% 12.2% 9.9% 9.6%
Free-cash-flow margin 16.7% 6.5% 10.8% 18.1% 11.5% 8.9% 7.4%
Free-cash-flow margin, 3-year average 15.9% 6.9% 8.6% 14.3% — 7.2% 8.6%
Stock pay / revenue 1.4% 0.7% 0.7% 3.0% 1.8% 1.1% 2.5%
Change in share count −3.7% −2.6% −2.5% −2.0% — −14.5% 0.5%

Median of all 33 companies we cover in research & consulting services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

33 research & consulting services companies
Measure Company Peer median Rank
Revenue growth Growth 10.9% 4.8% 11 of 33
Change in growth rate Growth +0.6pp +0.6pp 17 of 33
Operating margin Profitability 18.8% 6.1% 4 of 31
Net margin Profitability 11.3% 3.1% 8 of 33
Free-cash-flow margin Cash generation 16.7% 7.4% 4 of 33
Stock pay as % of revenue Cash generation 1.4% 2.6% 9 of 30
Long-term debt as % of assets Balance sheet 42.3% 22.7% 17 of 21
Change in share count Balance sheet -3.7% 0.6% 6 of 30
Days sales outstanding Balance sheet 61 days 63 days 14 of 29

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Workforce Solutions $2.6B 42.5% ▲ 6.1%
United States Consumer Information Solutions $2.1B 34.2% ▲ 9.8%
International $1.4B 23.3% ▲ 4.4%
Geography
Region Revenue Share YoY
United States $4.7B 76.7% ▲ 7.7%
Other Countries $498M 8.2% ▲ 4.4%
United Kingdom $326M 5.4% ▲ 7.6%
Australia $318M 5.2% ▲ 2.9%
Canada $271M 4.5% ▲ 2.5%

From Equifax's 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$19B
Institutions reporting
832
Shares held vs prior quarter
▼ 0.3%
Positions opened / closed
101 / 135

Top buyers and sellers, Q2 2026: 355 institutions bought and 483 sold ; the biggest buyer was Capital International Investors (+1.5M shares) and the biggest seller Cantillon Capital Management LLC (−1.8M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $1.5B 9.4M 7.8% ▼ 0.7%
Vanguard Capital Management LLC $1.2B 7.8M 6.5% ▼ 0.6%
Harris Associates L P $1.2B 7.4M 6.2% ▼ 1.1%
Vanguard Portfolio Management LLC $832M 5.2M 4.4% ▼ 0.5%
State Street Corp $825M 5.2M 4.3% ▲ 3.5%
Capital International Investors $823M 5.2M 4.3% ▲ 41.1%
Soroban Capital Partners LP $700M 4.4M 3.7% ▲ 5.4%
Massachusetts Financial Services Co $620M 3.9M 3.3% ▼ 17.7%
Morgan Stanley $526M 3.3M 2.8% ▼ 17.6%
Brown Advisory Inc $522M 3.3M 2.7% ▼ 9.9%
Geode Capital Management, LLC $499M 3.2M 2.6% ▼ 1.3%
AQR Capital Management LLC $416M 2.7M 2.2% ▲ 51.3%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Equifax's complete shareholder register. Values are as reported by the filers ; 4 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $464,928 1 trade by 1 insider, last 12 months Insider sales History → $33.5M 36 trades by 4 insiders · 100% under pre-set plans
Net ▼ $33M net selling
Insider Date Trade Shares Price Value
Gamble John W Jr EVP, CFO & COO October 29, 2026 Sell pre-set plan 4,000 $177.68 $710,720
Begor Mark W CEO October 23, 2026 Sell pre-set plan 33,667 $182.52 $6.1M
Begor Mark W CEO October 23, 2026 Sell pre-set plan 1,681 $185.20 $311,327
Begor Mark W CEO October 23, 2026 Sell pre-set plan 1,250 $183.40 $229,254
Begor Mark W CEO October 23, 2026 Sell pre-set plan 1,194 $186.73 $222,960
Gamble John W Jr EVP, CFO & COO September 3, 2026 Sell pre-set plan 4,500 $187.96 $845,820
Begor Mark W CEO July 24, 2026 Sell pre-set plan 21,543 $172.00 $3.7M
Begor Mark W CEO July 24, 2026 Sell pre-set plan 6,200 $171.26 $1.1M
Begor Mark W CEO July 24, 2026 Sell pre-set plan 4,112 $172.79 $710,512
Begor Mark W CEO July 24, 2026 Sell pre-set plan 2,936 $173.79 $510,241
Begor Mark W CEO July 24, 2026 Sell pre-set plan 1,300 $174.91 $227,386
Begor Mark W CEO July 24, 2026 Sell pre-set plan 600 $168.47 $101,085

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 50 trades and filings

In the last 12 months, 1 member of Congress disclosed 1 purchase and 1 sale of Equifax shares.

  • Gilbert Ray Cisneros, Jr.(D-CA 31):Sale (full), $1,001 - $15,000, traded April 14, 2026, filed May 8, 2026
  • Gilbert Ray Cisneros, Jr.(D-CA 31):Purchase, $1,001 - $15,000, traded March 13, 2026, filed April 7, 2026
  • Robert P. Bresnahan, Jr.(R-PA 8):Purchase, $1,001 - $15,000, traded April 8, 2025, filed May 8, 2025

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around February 3, 2027 estimated from the company's past filing pattern, not announced

  • October 20, 2026
  • July 21, 2026
  • April 21, 2026
  • February 4, 2026
  • October 21, 2025
  • July 22, 2025

Recent SEC filings

Data status

When each part of this page on Equifax was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Equifax in brief

What does Equifax do?
Equifax is a US-listed company in the research & consulting services industry. Its financial year ends in December.
What is Equifax's stock ticker?
Equifax trades under the ticker EFX on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Equifax's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Equifax reported revenue of $6.6B, 10.9% higher than a year earlier, according to its SEC filings.
What is Equifax's free cash flow?
Equifax's free-cash-flow margin is 16.7% of revenue over the trailing twelve months, ranking 4 of the 33 research & consulting services companies we cover.
What is Equifax's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Equifax's free cash flow after stock-based pay gives ~$200 per share in the base case, and ~$140–$280 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Equifax's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Capital Management LLC and Harris Associates L P. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Equifax buying back stock, and does it pay a dividend?
Equifax spent $1.2B on share repurchases over the trailing twelve months, and its diluted share count fell 3.7% over the year.
What is Equifax's market cap?
On November 2, 2026, Equifax's market capitalisation was about $23.1B, with a price-to-earnings ratio of 31.1 and net debt of $5B. Market figures come from third-party market data and may be delayed.
Does Equifax pay a dividend?
Yes: Equifax paid $260M in dividends over the trailing twelve months, a dividend yield of 1.15% and a payout ratio of 35.0%.
How much debt does Equifax have?
Equifax's debt-to-equity ratio is 116.4%, from its latest balance sheet (116.6% five years earlier). The financial health section below sets out its other solvency checks.
Who are Equifax's competitors?
In our Research & Consulting Services peer group, the companies closest to Equifax are Parsons Corp, Tetra Tech Inc, Transunion, NIQ Global Intelligence plc and FTI Consulting, Inc. The side-by-side comparison below sets their revenue, margins and growth against Equifax's.
Are insiders buying or selling Equifax stock?
Over the last 12 months, Equifax's directors and officers reported 1 open-market purchases and 36 sales on Form 4. The insider trading page charts every trade.
When is Equifax's next earnings date?
Around February 3, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Equifax announces its own schedule.